Ovation Science Announces Participation at MJ Unpacked Conference

2.4 min readPublished On: September 27th, 2022By

VANCOUVER, BC and LAS VEGAS, Sept. 27, 2022 Ovation Science Inc a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare®, today announced it will be participating and be taking new licensee meetings at the MJ Unpacked conference being held at the MGM Hotel in Las Vegas from September 28 to 30th, 2022. Ovation will participate as an exhibitor (Booth 218) and management will be available for one-on-one meetings throughout the event. MJ Unpacked brings together cannabis retailers, buyers, brands and investors. Ovation will be highlighting its licensing opportunities for its topical / transdermal formulations.

“I am looking forward to meeting with potential licensees for our award-winning transdermal formulations,” said Terry Howlett, CEO of Ovation Science. “With Ovation’s recent announcements of our new patent protection to 2041 and our new licensee for Oklahoma, Missouri, New Mexico and Mississippi, we anticipate a great deal of interest from potential licensees for other states. This conference allows us to showcase our products and take advantage of the opportunity to meet with industry executives that may be seeking new product lines like ours.”

Ovation leverages its expertise in the pharmaceutical industry to develop highly effective, proprietary products. What makes Ovation’s products different from any other topical cannabis products on the market is its superior delivery of CBD / THC and other cannabinoids using its proprietary skin delivery technology Invisicare®. Invisicare has over twenty years of research and development in the pharmaceutical industry; specifically, dermatology. Ovation formulates two types of topicals; ones that remain on the skin to deal with “skin issues” and transdermal creams that allow the CBD (cannabidiol), and/or the THC (tetrahydrocannabinol) and other cannabinoids to be absorbed through the skin into the bloodstream. Studies show Ovation’s products have a 10 times greater release of CBD to the skin and over 5 times greater penetration compared to other products tested.

About Ovation Science Inc.

Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including its CBD/THC and other cannabinoid formulations which are licensed out and also distributed under Ovation’s own brands; ARLO CBD Beauty and InVibe® MD (“health & wellness” line); all made with its patented Invisicare® skin delivery technology. The Invisicare technology enhances the delivery of ingredients to and through the skin and is protected by patents and proprietary formulations which cannot be duplicated. With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation’s management and science team have created a unique pipeline of over thirty proprietary medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas. Ovation earns revenues from royalties on licensees’ sales and the sale of Invisicare, along with revenue from its own product sales. Ovation has offices in Vancouver, BC Canada and Las Vegas, Nevada, USA.

(This information is primarily sourced from Ovation Science Inc. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

  • CBD Oil Market, CBD Skin Care Market, Industrial hemp Market, Medical Marijuana Market, Financial Results

CBD Oil Market to Register 31.50% CAGR by 2031

December 3rd, 2022|

NEWARK, Del - The global cannabidiol CBD oil market is anticipated to grow at an impressive compound annual growth rate (CAGR) of 31.50% annually over the projection period from 2021 to 2031. The global market ...